As we overcome the COVID crisis, and look to rebuild our economy and overcome future challenges, we need to learn from this experience and refuse to go back to the bad old days of red tape and stale technology. Photo via Getty Images

If you've logged onto a government website recently, you know that dealing with creaking, outdated government technology is about as much fun as a trip to the DMV. Held back by byzantine procurement rules, management-by-committee, and an aggressive commitment to decades-old UX principles, government websites and other tech tools are routinely confusing, horrible to use, and deeply inefficient.

Now, though, that could finally be changing. The COVID-19 pandemic has forced us all to rethink our relationships with the technologies we use, from Zoom calls to e-commerce services. Increasingly, government bodies are finding themselves forced to move faster, adopt more up-to-date technologies, and work with private-sector partners to meet new challenges and quickly bring their services into the 21st century.

Getting an education

One of the most dramatic examples comes in the realm of education. According to the U.S. Census Bureau, about 93 percent of school-age children have engaged in distance learning since the pandemic began, and four fifths of them relied on digital tech to take the place of classroom resources. But with access to digital tech at home strongly correlated to household income, governments and education departments have had to move quickly to ensure every child has access to laptops and web connections.

Not everyone is a fan of remote learning, and as a parent myself, I know how hard it can be to have kids at home. But one thing we should all be able to agree on is that if we're going to rely on digital learning, then we need to make sure it's available to everyone, including those families that don't have access to reliable computers and WiFi connections at home.

Achieving that rapidly and at scale has required remarkable flexibility and creativity from policymakers at all levels. Those that have succeeded have done so by brushing aside the red tape that has ensnared previous government tech initiatives, and instead working with private-sector partners to rapidly implement the solutions that are needed.

Lessons from Texas

Here in Texas, for instance, one in six public school students lacked access to high-speed internet connections at the start of the pandemic, and 30% lacked access to laptops or other learning devices. To speed the transition to remote learning, Gov. Greg Abbott and the Texas Education Agency (TEA) launched Operation Connectivity — a $400 million campaign to connect 5.5 million Texas public school students with a computer device and reliable internet connection. To date 4 million devices have been purchased and are being distributed to kids, opening doors to greater educational and economic opportunities. Further work is in progress to remove other connectivity barriers like slow connection speeds in rural areas to help students and all Texans.

Rolling out such an ambitious project to our state's 1,200 or so school districts could have been a disaster. After all, many government IT projects grind along for months or years without delivering the desired results — often at huge cost to taxpayers. But Operation Connectivity has been different because it's grounded in a true partnership between the government and private-sector players.

Facing urgent deadlines, government leaders turned to Gaby Rowe, former CEO of the Ion tech hub, to spearhead the project. As a tech innovator, Rowe brought entrepreneurial energy and a real understanding of the power of public-private partnerships, and drove Operation Connectivity from the blueprint to execution in a matter of weeks. Tech giants including Microsoft, SAP, and Hubspot also quickly joined the effort, helping to deliver cost-effective connectivity and hardware solutions to ensure that every kid in our state could get the education they deserve. Since then, Operation Connectivity has distributed over a million devices, including laptops and wireless hotspots, to families in need, with costs split between the state and individual districts.

Private sector edge

To get a sense of how private-sector knowhow can spur government tech transformation, consider my own company, Digital Glyde. As part of the Operation Connectivity effort, we were asked to help design and build the back-end software and planning infrastructure needed to coordinate effectively with hundreds of school district officials scattered all across our state.

Ordinarily, that kind of effort would require a drawn-out process of consultation, committee-work, and red tape. But facing an urgent need to help our state's children, we were given the freedom to move quickly, and were able to implement a viable system within just a few days.

By leveraging cutting-edge data-extraction and image-processing tools, we helped Operation Connectivity to automatically process invoices and match tech costs to available COVID relief funding in record time. We achieved 95% accuracy within three weeks of deployment to ensure school districts quickly received reimbursements for the hardware they were purchasing on behalf of their schoolchildren.

Building on success

Operation Connectivity is just one example of the ways in which government actors have embraced tech and leveraged private-sector assistance to chart their way through the COVID crisis. From contact-tracing programs to vaccine distribution programs, we're seeing governments taking a far more pragmatic and partnership-driven approach to technology.

Of course, not every experiment goes to plan. In Florida, government agencies decided to use web tools to manage vaccination appointments — but implemented that idea using a commercial website built to handle birthday party e-vites. Unsurprisingly, the results were chaotic, with users having to scramble to grab appointments as they were posted to the site, and seniors struggling to wrap their head around a website designed for young parents.

Such stories are a reminder that governments can't solve big problems simply by grabbing at whatever tech tools are nearest to hand. It's vital to find the right solutions, and to work with partners who understand the complexity and constraints that come with delivering public-sector services at scale.

As we overcome the COVID crisis, and look to rebuild our economy and overcome future challenges, we need to learn from this experience and refuse to go back to the bad old days of red tape and stale technology. In recent months, we've shown what can be done when we pull together, and combine real governmental leadership with private-sector innovation and efficiency. We'll need much more of this kind of teamwork and tech-enabled creativity in the months and years to come.

------

Varun Garg is the founder and CEO of Houston-based Digital Glyde

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Rice researchers score $45M from NIH for cancer-fighting tech

freshly funded

A research funding agency has deployed capital into a team at Rice University that's working to develop a technology that could cut cancer-related deaths in half.

Rice researchers received $45 million from the National Institutes of Health's Advanced Research Projects Agency for Health, or ARPA-H, to scale up development of a sense-and-respond implant technology. Rice bioengineer Omid Veiseh leads the team developing the technology as principal investigator.

“Instead of tethering patients to hospital beds, IV bags and external monitors, we’ll use a minimally invasive procedure to implant a small device that continuously monitors their cancer and adjusts their immunotherapy dose in real time,” he says in a news release. “This kind of ‘closed-loop therapy’ has been used for managing diabetes, where you have a glucose monitor that continuously talks to an insulin pump. But for cancer immunotherapy, it’s revolutionary.”

Joining Veiseh on the 19-person research project named THOR, which stands for “targeted hybrid oncotherapeutic regulation,” is Amir Jazaeri, co-PI and professor of gynecologic oncology at the University of Texas MD Anderson Cancer Center. The device they are developing is called HAMMR, or hybrid advanced molecular manufacturing regulator.

“Cancer cells are continually evolving and adapting to therapy. However, currently available diagnostic tools, including radiologic tests, blood assays and biopsies, provide very infrequent and limited snapshots of this dynamic process," Jazaeri adds. "As a result, today’s therapies treat cancer as if it were a static disease. We believe THOR could transform the status quo by providing real-time data from the tumor environment that can in turn guide more effective and tumor-informed novel therapies.”

With a national team of engineers, physicians, and experts across synthetic biology, materials science, immunology, oncology, and more, the team will receive its funding through the Rice Biotech Launch Pad, a newly launched initiative led by Veiseh that exists to help life-saving medical innovation scale quickly.

"Rice is proud to be the recipient of the second major funding award from the ARPA-H, a new funding agency established last year to support research that catalyzes health breakthroughs," Rice President Reginald DesRoches says. "The research Rice bioengineer Omid Veiseh is doing in leading this team is truly groundbreaking and could potentially save hundreds of thousands of lives each year. This is the type of research that makes a significant impact on the world.”

The initial focus of the technology will be on ovarian cancer, and this funding agreement includes a first-phase clinical trial of HAMMR for the treatment of recurrent ovarian cancer that's expected to take place in the fourth year of THOR’s multi-year project.

“The technology is broadly applicable for peritoneal cancers that affect the pancreas, liver, lungs and other organs,” Veiseh says. “The first clinical trial will focus on refractory recurrent ovarian cancer, and the benefit of that is that we have an ongoing trial for ovarian cancer with our encapsulated cytokine ‘drug factory’ technology. We'll be able to build on that experience. We have already demonstrated a unique model to go from concept to clinical trial within five years, and HAMMR is the next iteration of that approach.”

TMC again expands global impact with new Netherlands partnership

breaking news

The Texas Medical Center may be based in Houston, but the organization has again grown its global impact.

Since 2016, TMC’s BioBridges have worked with 88 startup companies. Those include strategic alliances with four other countries. Australia, the United Kingdom, Denmark and Ireland are all among TMC’s BioBridges partners. As of today, add the Netherlands to that list.

On September 27, TMC president and CEO, William F. McKeon, and Carmen van Vilsteren, chair of Health~Holland, Top Sector Life Sciences & Health (LSH), signed an agreement in Rotterdam. The TMC Netherlands BioBridge Memorandum of Understanding codifies the innovative goals of the partnership. Essentially, the BioBridge program provides a means for entrepreneurs, researchers, clinicians and industry partners from other countries to access the US market, as well as TMC experts.

“The TMC Netherlands BioBridge represents an unparalleled opportunity for collaboration and growth,” Ashley McPhail, chief external affairs & administration officer at Texas Medical Center said in a press release. “The Netherlands has solidified its position as a global leader in the field of life sciences and health, with a thriving ecosystem of research institutions, innovative companies, and highly skilled professionals. This strategic partnership will bring positive benefits to patients, clinicians and industry partners on a global scale.”

This lifeline for international healthcare companies makes expansion into the United States far smoother. The Global Innovators Launch Pad allows for startup founders to take part in a 10-week residency at the TMC Innovation Factory that will teach them about foundational infrastructure, clinical evidence and funding in the US.

“Since Texas is an important hub for innovation in the MedTech and digital health sectors, the collaboration with Texas Medical Center creates opportunities for Dutch companies looking to expand their international reach. Vice versa, it gives companies in Texas access to the vibrant Dutch Life Sciences & Health sector,” said van Vilsteren.

That exchange includes members of the TMC gaining the opportunity to participate in the Health~Holland Visitors Programme (HVP), “Shaping the Healthcare of the Future.”

The annual event invites high-level representatives from the private sector, NGOs, knowledge institutions, healthcare providers and different tiers of government to share their expertise.

It's the fifth partnership of its kind for TMC, with the last one being with Ireland, announced last year. TMC's other global initiatives include accelerators with Denmark and the United Kingdom, both announced earlier this year.

Houston startup founders prepare to scale globally following Shark Tank success

HOUSTON INNOVATORS PODCAST EPISODE 205

While Milkify's founders — husband and wife team Pedro Silva and Berkley Luck — secured partners on a popular business pitch and investment show, the entire experience almost didn't happen.

Silva and Luck, who got her PhD in molecular and biomedical s at Baylor College of Medicine, founded the company to provide breast milk freeze drying as a service to Houston-area families. Now, Milkify has customers across the country, but the duo didn't know if going through the process would be worth the investment and publicity, or if it would just be a distraction.

"The competitor in me wanted to be the first breast milk company to go on the show and to tell our story to the world — to show the world what my wife came up with that we thought was so great," Silva says on the Houston Innovators Podcast. "It was probably the scariest 45 minutes of my life."

But the sharks bit. Milkify's episode aired in April, and two investors — Gwyneth Paltrow and Lori Greiner — agreed to a $400,000 convertible note for 20 percent equity in the company. Paltrow even said on the show that she would have used the service when she was breastfeeding.

"It was empowering," Luck says of getting to wear her white coat on TV and share the story of how she came up with the idea of Milkify. "It was important to me when we went on the show to express that this had a scientific basis, that we didn't start this lightly, and that we've made huge strides in doing this in the absolute safest way possible."

Silva says they can't talk about some of the details of the show or the deal, but since then, Milkify has reached new customers, received additional investment interest, grown its team, and built out its plan to scale, the founders shared on the podcast. The team also shares its big-picture scale plans, which include tapping international partners to potentially take Milkify's tech global.

"Our vision is for every family to have access to breast milk formula, but instead of re-creating breast milk in a lab, we're doing it with mom's own milk," Silva says, mentioning a partnership with a breast milk bank that will convert its operation from freezing to freeze drying donated milk. "We're also working with groups in the UK and Australia to launch similar services using our patented technology."

"By the end of the year, we hope to see some announcements with those partnerships across the globe."

From the beginning, the importance of Milkify's team has been on supporting working parents to give them the best way to care for their families, Silva says. And for Luck — who says she's proud of the integrity Milkify has at its core despite competitors offering lower-quality and, in some cases, dangerous alternatives — she sees a lot of research benefits for the company.

"It's amazing to be at this leading edge, not just of innovation but of research, and to be able to still put out meaningful advances as an industry partner, not just as an academic," Luck says, adding that she hopes to be able to continue to contribute to the ongoing research into breast milk.

Luck and Silva share more about their Shark Tank experience, their co-founder strengths, and the future of Milkify on the podcast. Listen to the interview here — or wherever you stream your podcasts — and subscribe for weekly episodes.